Biomedical Engineering Reference
In-Depth Information
7. Stephenson, ML, and Zamecnik, PC (1978). Inhibition of Rous sarcoma
viral RNA translation by a specific oligodeoxyribonucleotide.
Proc Natl
. pp. 285-288.
8. Kurreck, J (2003). Antisense technologies. Improvement through novel
chemical modifications.
Acad Sci USA
,
75
Eur J Biochem
,
270
. pp. 1628-1644.
9. Warren, L,
. (2010). Highly efficient reprogramming to pluripotency
and directed differentiation of human cells with synthetic modified
mRNA.
et al
Cell Stem Cell
,
7
. pp. 618-630.
10. Kormann, MS,
. (2011). Expression of therapeutic proteins after
delivery of chemically modified mRNA in mice.
et al
Nat Biotechnol
,
29
.
pp. 154-157.
11. Luo, D, and Saltzman, WM (2000). Synthetic DNA delivery systems.
Nat
Biotechnol
,
18
. pp. 33-37.
12. DiGiusto, DL,
. (2010). RNA-based gene therapy for HIV with
lentiviral vector-modified CD34(+) cells in patients undergoing
transplantation for AIDS-related lymphoma.
et al
Sci Transl Med
,
2
.
pp. 36-43.
13. Prasad, SC, and Roy, I (2008). Nucleic acid based therapeutic molecules.
Curr Res Inf Pharm Sci
. p. 7.
14. Ng, EW, Shima, DT, Calias, P, Cunningham, ET, Jr., Guyer, DR, and Adamis,
AP (2006). Pegaptanib, a targeted anti-VEGF aptamer for ocular
vascular disease.
,
9
. pp. 123-132.
15. Fire, A, Xu, S, Montgomery, MK, Kostas, SA, Driver, SE, and Mello, CC
(1998). Potent and specific genetic interference by double-stranded
RNA in Caenorhabditis elegans.
Nat Rev Drug Discov
,
5
. pp. 806-811.
16. Zamore, PD, Tuschl, T, Sharp, PA, and Bartel, DP (2000). RNAi: double-
stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23
nucleotide intervals.
Nature
,
391
. pp. 25-33.
17. Singerman, L (2009). Combination therapy using the small interfering
RNA bevasiranib.
Cell
,
101
Retina
,
29
. pp. S49-50.
18. Davis, ME,
. (2010). Evidence of RNAi in humans from systemi-
cally administered siRNA via targeted nanoparticles.
et al
Nature
,
464
.
pp. 1067-1070.
19. Castanotto, D, and Rossi, JJ (2009). The promises and pitfalls of RNA-
interference-based therapeutics.
. pp. 426-433.
20. Mayer, G (2009). The chemical biology of aptamers.
Nature
,
457
Angew Chem Int Ed
. pp. 2672-2689.
21. Syed, MA, and Pervaiz, S (2010). Advances in aptamers.
Engl
,
48
Oligonuc-
leotides
,
20
. pp. 215-224.
Search WWH ::
Custom Search